Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer

Metastatic urothelial carcinoma of the bladder is an aggressive malignancy with poor prognosis, reflecting a lack of effective systemic therapies. The current standard of care includes multiagent platinum-based chemotherapy; however a majority of patients do not respond to treatment and most eventua...

Descripción completa

Detalles Bibliográficos
Autores principales: Aydin, Ahmet Murat, Woldu, Solomon L, Hutchinson, Ryan C, Boegemann, Martin, Bagrodia, Aditya, Lotan, Yair, Margulis, Vitaly, Krabbe, Laura-Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352238/
https://www.ncbi.nlm.nih.gov/pubmed/28331342
http://dx.doi.org/10.2147/OTT.S109453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352238/
https://www.ncbi.nlm.nih.gov/pubmed/28331342
http://dx.doi.org/10.2147/OTT.S109453

Ejemplares similares